文献库，生知库 | 链接生命科学的每一步

Epigenetic changes during hematopoietic cell granulocytic differentiation--comparative analysis of primary CD34+ cells, KG1 myeloid cells and mature neutrophils

造血细胞粒细胞分化过程中的表观遗传变化——原代CD34+细胞、KG1髓系细胞和成熟中性粒细胞的比较分析

Navakauskienė, Rūta; Borutinskaitė, Veronika V; Treigytė, Gražina; Savickienė, Jūratė; Matuzevičius, Dalius; Navakauskas, Dalius; Magnusson, Karl-Eric

表观遗传

Midgestational injection of highly expanded human CD34+ cells increases lineages of human immune cells and supports thymic development in RAG2-/-IL2RG-/Y SCID pigs.

在 RAG2-/-IL2RG-/Y SCID 猪的妊娠中期注射高度扩增的人类 CD34+ 细胞可增加人类免疫细胞谱系，并支持胸腺发育。

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2026.1751541

Forster Ahlea M, Kress Amanda Ahrens, Kiupel Matti, Cunnick Joan, Webster Dennis A, Campbell Jarryd M, Watson Adrienne L, Gafni Ohad, Carlson Daniel F, Moriarity Branden S, Webber Beau R, Napiwocki Brett, Daharsh Lance, Ross Jason W, Sauer Mary B, Tuggle Christopher K

Correction to "CD34dim Cells Identified as Pluripotent Stem Cell-Derived Definitive Hemogenic Endothelium Purified Using Bone Morphogenetic Protein 4"

对“CD34dim 细胞被鉴定为多能干细胞衍生的终末造血内皮细胞，该细胞通过骨形态发生蛋白 4 纯化”的更正

期刊:Cell Proliferation

影响因子:5.6

doi:10.1111/cpr.70105

Corrigendum to "Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and Feasibility. Ophthalmol Sci. 2026;6:100905"

更正“玻璃体内注射自体CD34+干细胞治疗中心性视网膜静脉阻塞的随机研究（干细胞治疗视网膜静脉阻塞[TRUST]报告1）：安全性和可行性。眼科科学。2026;6:100905”

期刊:Ophthalmology Science

影响因子:4.6

doi:10.1016/j.xops.2025.101019

Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and Feasibility

玻璃体内注射自体CD34+干细胞治疗中心性视网膜静脉阻塞的随机研究（干细胞治疗视网膜静脉阻塞[TRUST]报告1）：安全性和可行性

期刊:Ophthalmology Science

影响因子:4.6

doi:10.1016/j.xops.2025.100905

Park, Susanna S; McCormack, Jennifer; Salazar, Dagmar; King, Jacquie S; Salvador, Marisa; Bauer, Gerhard; Fury, Brian; Abedi, Mehrdad; Moshiri, Ala; Macias, Denise; Moussa, Kareem; Kondapaka, Radhika; Lindblad, Robert; Hoeg, Rasmus; Nolta, Jan A

Fucosylation enhances CD34⁺ hematopoietic stem cell homing and longevity via E-selectin-mediated adhesion and signaling

岩藻糖基化通过E-选择素介导的粘附和信号传导增强CD34⁺造血干细胞的归巢和寿命

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-026-15614-1

Al-Amoodi, Asma S; Alghuneim, Arwa A; Malki, Jana S; Nozue, Shuho; Li, Yanyan; Kai, Jing; Zhang, Huoming; Bensaddek, Dalila; Abdel-Aziz, Amal Kamal; Habuchi, Satoshi; Merzaban, Jasmeen S

Comparison of CD34+ cell enumeration between flow cytometric analysis and ADAMII-CD34 image-based fluorescence cell counter

流式细胞术分析与基于ADAMII-CD34图像的荧光细胞计数器对CD34+细胞计数结果的比较

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0345611

Thedsawad, Anchalee; Boonmoh, Sirikwan; Taka, Orathai; Owattanapanich, Weerapat

Distinct immunophenotypic and clinical features of TP53-mutated acute myeloid leukemia: high CD34/CD41 expression and lower leukocyte counts

TP53突变型急性髓系白血病的独特免疫表型和临床特征：CD34/CD41高表达和白细胞计数低

期刊:Annals of Hematology

影响因子:2.4

doi:10.1007/s00277-026-07001-4

Park, Songyi; Kim, Sang-A; Kim, Sheehyun; Kim, Seon Young; Lee, Ji Yun; Byun, Ja Min; Hwang, Sang Mee; Lee, Jeong-Ok; Koh, Youngil; Hong, Junshik; Chang, Yoon Hwan; Kim, Hyun Kyung; Bang, Soo-Mee; Kim, Inho; Yoon, Sung-Soo; Shin, Dong-Yeop

CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms

骨髓增生性肿瘤随访期间CD34阳性循环细胞的定量分析

期刊:Annals of Hematology

影响因子:2.4

doi:10.1007/s00277-026-06755-1

Demoy, Marine; Bauvais, Maxence; Vely, Agathe; Nicol, Thomas; Riou, Jérémie; Le Jeanne, Hortense; Bauduin, Aurélien; Rambaud, Hubert; Boyer, Françoise; Geneviève, Franck; Boussaroque, Agathe; Copin, Marie-Christine; Ugo, Valérie; Orvain, Corentin; Luque Paz, Damien

CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia

CD34 和 CD38 是急性 B 淋巴细胞白血病的预后生物标志物。

Epigenetic changes during hematopoietic cell granulocytic differentiation--comparative analysis of primary CD34+ cells, KG1 myeloid cells and mature neutrophils

造血细胞粒细胞分化过程中的表观遗传变化——原代CD34+细胞、KG1髓系细胞和成熟中性粒细胞的比较分析

Midgestational injection of highly expanded human CD34+ cells increases lineages of human immune cells and supports thymic development in RAG2-/-IL2RG-/Y SCID pigs.

在 RAG2-/-IL2RG-/Y SCID 猪的妊娠中期注射高度扩增的人类 CD34+ 细胞可增加人类免疫细胞谱系，并支持胸腺发育。

Correction to "CD34dim Cells Identified as Pluripotent Stem Cell-Derived Definitive Hemogenic Endothelium Purified Using Bone Morphogenetic Protein 4"

对“CD34dim 细胞被鉴定为多能干细胞衍生的终末造血内皮细胞，该细胞通过骨形态发生蛋白 4 纯化”的更正

Corrigendum to "Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and Feasibility. Ophthalmol Sci. 2026;6:100905"

更正“玻璃体内注射自体CD34+干细胞治疗中心性视网膜静脉阻塞的随机研究（干细胞治疗视网膜静脉阻塞[TRUST]报告1）：安全性和可行性。眼科科学。2026;6:100905”

Randomized Study of Intravitreal Autologous CD34+ Stem Cells in Central Retinal Vein Occlusion (Treatment of Retinal vein occlusion Using STem cells [TRUST] Report 1): Safety and Feasibility

玻璃体内注射自体CD34+干细胞治疗中心性视网膜静脉阻塞的随机研究（干细胞治疗视网膜静脉阻塞[TRUST]报告1）：安全性和可行性

Fucosylation enhances CD34⁺ hematopoietic stem cell homing and longevity via E-selectin-mediated adhesion and signaling

岩藻糖基化通过E-选择素介导的粘附和信号传导增强CD34⁺造血干细胞的归巢和寿命

Comparison of CD34+ cell enumeration between flow cytometric analysis and ADAMII-CD34 image-based fluorescence cell counter

流式细胞术分析与基于ADAMII-CD34图像的荧光细胞计数器对CD34+细胞计数结果的比较

Distinct immunophenotypic and clinical features of TP53-mutated acute myeloid leukemia: high CD34/CD41 expression and lower leukocyte counts

TP53突变型急性髓系白血病的独特免疫表型和临床特征：CD34/CD41高表达和白细胞计数低

CD34-positive circulating cells quantification during follow-up in myeloproliferative neoplasms

骨髓增生性肿瘤随访期间CD34阳性循环细胞的定量分析